# [18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer

> **NCT06580015** · NA · ACTIVE_NOT_RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- Prostate Carcinoma

## Interventions

- **PROCEDURE:** Computed Tomography
- **OTHER:** Flotufolastat F-18 Gallium
- **OTHER:** Medical Device Usage and Evaluation
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT06580015
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-03-25
- **Primary completion:** 2027-01-09
- **Final completion:** 2027-01-09
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06580015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06580015, "[18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06580015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*